-
Reply: Ubiquitary Presence of Hypoattenuated Lesions Following Transcatheter Aortic Valve Replacement JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-11 Yeonwoo Choi MD, Hyun Jung Koo MD, Duk-Woo Park MD
-
Longitudinal Patient Data: The “Achilles Heel” of Procedural Cardiovascular Registries JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-11 Ralph G. Brindis MD MPH, Steven M. Bradley MD MPH
-
Big Picture of TAVR in Small Annuli: What Matters Most? JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-11 Naoki Misumida MD, Charanjit S. Rihal MD MBA
-
Ubiquitary Presence of Hypoattenuated Lesions Following Transcatheter Aortic Valve Replacement JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-11 Marco Moscarelli MD PhD MRes, Vincenzo Pernice MD, Giulia Sollami MD, Giuseppe Speziale MD PhD, Khalil Fattouch MD PhD
-
A Segmentalized Approach to Femoropopliteal Chronic Total Occlusions JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-11 Mehdi H. Shishehbor DO MPH PhD, Tarek A. Hammad MD
-
TAVR Procedure-Related Stroke: When the Safety Net Fails JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-11 Paul Guedeney MD PhD, Olivier Barthelemy MD, Gilles Montalescot MD PhD
-
Early Experience With the Innovalve Transcatheter Mitral Valve Replacement System JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-11 David Meerkin MBBS, Victor Guetta MD, Tamaz Shaburishvili MD, Irakli Gogorishvili MD, Zviad Kipiani MD, Boris Orlov MD, Teona Zirakashvili MD, Natia Bachilava MD, Adi Butnaru MD, Avi Avner DVM, Orly Goitein MD, Ehud Raanani MD
-
Conservative Management of an Iatrogenic Left Ventricular Aneurysm With Rupture of the Endocardium and Myocardium JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-11 Weijng Zhang MD, Dawei Lin MD, Shasha Chen MD, Xiaochun Zhang MD, Daxin Zhou MD, Wenzhi Pan MD, Junbo Ge MD
-
Percutaneous Transeptal Transcatheter Mitral Valve Replacement Following Failed Surgical Edge-to-Edge Repair JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-11 Andrea Scotti MD, Edwin C. Ho MD, Julio Echarte-Morales MD, Matteo Sturla MD, Mei Chau MD, Claire A. Joseph DO, Leandro Slipczuk MD, Lauren Ranard MD, Torsten P. Vahl MD, Juan F. Granada MD, Azeem Latib MD
-
Left Ventricular Outflow Tract Obstruction After Transseptal Mitral Valve Replacement: Does HighLife Clarity Solve It? JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-11 Mirjam Keßler MD, Leonhard-Moritz Schneider MD, Wolfgang Rottbauer MD
-
Evolut PRO and SAPIEN ULTRA Performance in Small Aortic Annuli: The OPERA-TAVI Registry JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-11 Andrea Scotti MD, Matteo Sturla MD, Giuliano Costa MD, Francesco Saia MD, Thomas Pilgrim MD, Mohamed Abdel-Wahab MD, Philippe Garot MD, Caterina Gandolfo MD, Luca Branca MD, Ignacio Amat Santos MD, Darren Mylotte MD, Francesco Bedogni MD, Ole De Backer MD, Luis Nombela Franco MD, John Webb MD, Flavio Luciano Ribichini MD, Andrea Mainardi MD, Stefano Andreaggi MD, Alessandro Mazzapicchi MD, Daijiro
The performance of latest iteration transcatheter aortic valve replacement platforms in patients with small aortic anatomy remains underexplored. The aim of this study was to evaluate effectiveness and performance between the self-expanding (SE) Evolut PRO and PRO+ and the balloon-expandable (BE) SAPIEN ULTRA in patients with small aortic annuli. Data from the OPERA-TAVI (Comparative Analysis of Evolut
-
Inter-Rater Reliability for the Amputation Endpoint in the National Vascular Quality Initiative JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-11 Kim G. Smolderen PhD, Gaëlle Romain PhD, Lindsey Scierka MD, Jacob Cleman MD, Mufti Mushfiqur Rahman MD, Waleed Tariq Siddiqui MD, Freddy Duarte Lau MD, Jialin Mao MD PhD, Narjes Akhlaghi MD, Adrian Acuna Higaki BS, Xavier P. Fowler MD, Matthew C. Carroll MD, Katherine Telma MD, Thomas Alvermann BS, Vincent Baribeau BS, Philip.P. Goodney MD MS, Carlos Mena-Hurtado MD
National quality reporting efforts after revascularization for peripheral artery disease (PAD) are ongoing. Validation of endpoints are necessary in national quality registries. This study sought to examine the interrater reliability for the endpoint of major amputation at 1 year in the Vascular Quality Initiative (VQI) registry and the Medicare-linked Vascular Quality Initiative registry (VQI-VISION)
-
The Impact of Cerebral Embolic Protection Devices on Characteristics and Outcomes of Stroke Complicating TAVR JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-11 Amos Levi MD, Matthias Linder MD, Moritz Seiffert MD, Guy Witberg MD MPH, Thomas Pilgrim MD, Daijiro Tomii MD, Yeela Tamlor Barkan MD PhD, Nicolas M. Van Mieghem MD PhD, Rik Adrichem MD, Pablo Codner MD, David Hildick-Smith MD, Sandeep Arunothayaraj MBBS, Leor Perl MD, Ariel Finkelstein MD, Itamar Loewenstein MD, Ole De Backer MD PhD, Rani Barnea MD, Giuseppe Tarantini MD PhD, Luca Nai Fovino MD PhD
Acute ischemic stroke remains a serious complication of transcatheter aortic valve replacement (TAVR). Cerebral embolic protection devices (CEPD) were developed to mitigate the risk of acute ischemic stroke complicating TAVR (AISCT). However, the existing body of evidence does not clearly support CEPD efficacy in AISCT prevention. In a cohort of patients with AISCT, we aimed to compare the characteristics
-
Intraluminal vs Subintimal Drug-Coated Balloon Angioplasty for the Treatment of Femoropopliteal Chronic Total Occlusions JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-11 Taku Toyoshima MD, Mitsuyoshi Takahara MD PhD, Osamu Iida MD PhD, Yusuke Tomoi MD, Daizo Kawasaki MD PhD, Akiko Tanaka MD, Yasutaka Yamauchi MD PhD, Kazuki Tobita MD, Amane Kozuki MD PhD, Masahiko Fujihara MD, Yoshiharu Higuchi MD PhD, Yoshimitsu Soga MD PhD, POPCORN Investigators
Whether intraluminal drug-coated balloon (DCB) angioplasty is superior to subintimal DCB angioplasty regarding femoropopliteal (FP) chronic total occlusion (CTO) outcomes has not been systematically determined. The aim of this study was to compare the 1-year clinical outcomes of intraluminal and subintimal DCB angioplasty for the treatment of patients with symptomatic FP CTO. This subanalysis of POPCORN
-
Commissural and Coronary Alignment Techniques: It Is All Right! JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-06 Didier Tchétché MD, Vincenzo Cesario MD
-
Late Sinus Sequestration After TAVR-in-TAVR Rescued by Coronary Artery Bypass Grafting JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-06 Tomoki Ochiai MD, Futoshi Yamanaka MD, Tsuyoshi Yamabe MD, Hirokazu Miyashita MD, Noriaki Moriyama MD, Koki Shishido MD, Kiyotaka Iwasaki PhD, Shigeru Saito MD
-
Commissural vs Coronary Alignment to Avoid Coronary Overlap With THV-Commissure in TAVR: A CT-Simulation Study JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-06 Manish Vinayak MD, Gilbert H.L. Tang MD MSc MBA, Keva Li BS, Megan Berdan, Anoop N. Koshy MD PhD, Sahil Khera MD MPH, Stamatios Lerakis MD PhD, George D. Dangas MD PhD, Samin K. Sharma MD, Annapoorna S. Kini MD, Parasuram Krishnamoorthy MD
Coronary alignment is proposed as an alternative to commissural alignment for reducing coronary overlap during transcatheter aortic valve replacement (TAVR). However, largescale studies are lacking. This study aimed to determine the incidence of coronary overlap with commissural vs coronary alignment using computed tomography (CT) simulation in patients undergoing TAVR evaluation. In 1,851 CT scans
-
Coronary Cannulation Following TAVR Using Self-Expanding Devices With Commissural Alignment: The RE-ACCESS 2 Study JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-03-06 Giuliano Costa MD, Sofia Sammartino MD, Orazio Strazzieri MD, Silvia Motta MD, Valentina Frittitta MD, Elena Dipietro MD, Alessandro Comis MD, Mariachiara Calì MD, Valeria Garretto MD, Cristina Inserra MD, Maria Teresa Cannizzaro MD, Carmelo Sgroi MD, Corrado Tamburino MD PhD, Marco Barbanti MD
Coronary re-engagement after transcatheter aortic valve replacement (TAVR) using self-expanding transcatheter heart valves (THVs) systematically implanted using commissural alignment (CA) techniques has been poorly investigated. The aim of this study was to evaluate unsuccessful coronary cannulation, and its predictors, after TAVR using self-expanding devices implanted using CA techniques. RE-ACCESS
-
Reply: Sirolimus- vs Paclitaxel-Coated Balloons: It Is Only the Start JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Patrick W. Serruys MD PhD, Kai Ninomiya MD, Yoshinobu Onuma MD PhD
-
Tricuspid Transcatheter Orthotopic and Heterotopic Replacement Screening F.A.I.L.: First Attempt In Learning! JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Alessandro Sticchi MD, Marco De Carlo MD
-
ANOCA and the Endothelium: A Link That Can NO Longer Be Ignored JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Thabo Mahendiran BMBCh MD, Bernard De Bruyne MD PhD
-
Sirolimus- vs Paclitaxel-Coated Balloons: It Is Only the Start JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Anton Camaj MD MS, Pier Pasquale Leone MD MSc, Annapoorna Kini MD, Samin K. Sharma MD
-
Dissecting the Fall From Grace of Antegrade Dissection Re-Entry Techniques in Chronic Total Occlusion PCI JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Ashish Pershad MD MS
-
Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement: The TriACT Registry JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Daniel Hagemeyer MD, Anas Merdad MD, Laura Villegas Sierra MD, Andrea Ruberti MD, Faraj Kargoli MD, Marine Bouchat MD, Mauro Boiago MD, Aris Moschovitis MD, Djeven P. Deva MD, Lukas Stolz MD, Geraldine Ong MD MSc, Mark D. Peterson MD PhD, Nicolo Piazza MD, Maurizio Taramasso MD, Nicolas Dumonteil MD, Thomas Modine MD, Azeem Latib MD, Fabien Praz MD, Jörg Hausleiter MD, Neil P. Fam MD MSc
Transcatheter tricuspid valve replacement (TTVR) abolishes tricuspid regurgitation (TR) and has emerged as a definitive treatment for TR. The purpose of this multicenter, observational study was to determine the clinical characteristics and short-term outcomes of patients with TR screened for TTVR. Patients underwent TTVR screening at 7 centers on a compassionate-use basis. The primary endpoints were
-
Mitral Transcatheter Edge-to-Edge Repair: Bridging the Gap Between Clinical Trials and Real-World JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Andrea Scotti MD, Azeem Latib MD
-
Coronary Vasomotor Dysfunction Is Associated With Cardiovascular Events in Patients With Nonobstructive Coronary Artery Disease JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Yoshihisa Kanaji MD PhD, Ali Ahmad MD, Sara Jaskanwal Deep Singh MBChB, Ilke Ozcan MD, Nadia Akhiyat MD MS, Abhiram Prasad MD PhD, Claire E. Raphael MBBS PhD, Tsunekazu Kakuta MD PhD, Lilach O. Lerman MD PhD, Amir Lerman MD
Coronary vasomotor dysfunction (CVDys) can be comprehensively classified on the basis of anatomy and functional mechanisms. The aim of this study was to evaluate the association between different CVDys phenotypes and outcomes in patients with angina and nonobstructive coronary artery disease (ANOCA). Patients with ANOCA who underwent coronary reactivity testing using an intracoronary Doppler guidewire
-
Generalizing Tricuspid Clinical Trial Results to the “Real World” JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Mackram F. Eleid MD
-
Association Between Clinical Trial Participation Status and Outcomes With Mitral Transcatheter Edge-to-Edge Repair JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-26 Amro Aglan MD, Ahmed Maraey MD, Ayman R. Fath MD, Hadeer Elsharnoby MD, Wael Abdelmottaleb MD MSc, Ahmed M. Elzanaty MD MPH, Mahmoud Khalil MD, Sourbha S. Dani MD MSc, Marwan Saad MD PhD, Islam Y. Elgendy MD
Clinical trials have demonstrated the efficacy and safety of mitral transcatheter edge-to-edge repair (M-TEER) for selected patients with severe mitral regurgitation. However, the generalizability of trial results to real-world patients remains uncertain. The authors aimed to compare baseline characteristics and in-hospital outcomes among trial participants with nonparticipants undergoing M-TEER. Using
-
A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Oriol Rodriguez-Leor MD PhD, Ana Belen Cid-Alvarez MD PhD, Maria Lopez-Benito MD PhD, Nieves Gonzalo MD PhD, Victoria Vilalta MD PhD, Jose Antonio Diarte de Miguel MD PhD, Leticia Fernandez López MD, Alfonso Jurado-Roman MD PhD, Alejandro Diego MD PhD, Juan Francisco Oteo MD PhD, Carlos Cuellas MD PhD, Ramiro Trillo MD PhD, Alejandro Travieso MD PhD, Fernando Alfonso MD PhD, Xavier Carrillo MD PhD
Intravascular lithotripsy (IVL) has demonstrated effectiveness in the treatment of calcified lesions in selected patients with stable coronary disease. The authors sought to assess the performance of coronary IVL in calcified coronary lesions in a real-life, all comers, setting. The REPLICA-EPIC18 study prospectively enrolled consecutive patients treated with IVL in 26 centers in Spain. An independent
-
Real-World Experience of Transcatheter Mitral Valve Replacement: A Promising Glimpse Into the Future? JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Syed Zaid MD, Gilbert H.L. Tang MD MSc MBA
-
Transapical Mitral Valve Replacement: 1-Year Results of the Real-World Tendyne European Experience Registry JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Michaela M. Hell MD, Mirjam G. Wild MD, Stephan Baldus MD, Tanja Rudolph MD, Hendrik Treede MD, Anna Sonia Petronio MD, Thomas Modine MD, Martin Andreas MD PhD, Augustin Coisne MD PhD, Alison Duncan MD PhD, Luis Nombela Franco MD PhD, Fabien Praz MD, Hendrik Ruge MD, Lenard Conradi MD, Andreas Zierer MD, Amedeo Anselmi MD PhD, Nicolas Dumonteil MD, Georg Nickenig MD, Miguel Piñón MD PhD, Sebastian
Early studies of the Tendyne transcatheter mitral valve replacement (TMVR) showed promising results in a small selective cohort. The authors present 1-year data from the currently largest commercial, real-world cohort originating from the investigator-initiated TENDER (Tendyne European Experience) registry. All patients from the TENDER registry eligible for 1-year follow-up were included. The primary
-
Bridging the Gap: An Unusual Cause of Acute Coronary Syndrome JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Alec Vishnevsky MD, David L. Fischman MD
-
Fate of Box Fracture of Calcified Plaque After Intravascular Lithotripsy: Insights From Optical Coherence Tomography JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Yuki Katagiri MD PhD, Akihiro Tobe MD, Seiji Yamazaki MD, Yoshinobu Onuma MD PhD, Patrick W. Serruys MD PhD, Shigeru Saito MD
-
A Phantom Echocardiographic Figure-of-Eight Image From Disc-Structured Occluder Can Be Artifactual and Truly Ominous JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Lanqi Hua, Sheetal Patel, Kellie Glover, Ruihai Zhou
-
Coronary Stent Placement-Induced Intramural Hematoma of the Interventricular Septum JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Junwen Wang, Xin Wei, Yuan Feng, Yong Peng
-
Fractional Flow Reserve–Guided Drug-Coated Balloon vs Drug-Eluting Stent for de Novo Non-Small Coronary Lesions JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Delong Chen, Abuduwufuer Yidilisi, Yuxuan Zhang, Jiacheng Fang, Yiyue Zheng, Feng Gao, Weiming Li, Hao Zhou, Yan Chen, Dongsheng Lu, Jian'an Wang, Jun Jiang
-
A Partial-Demembrane Method to Protect the Aberrant Right Subclavian Artery in Coarctation of the Aorta JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Ruitao Li, Xiang Li, Qiao Li, Yuan Feng
-
Between a Rock and a Hard Place: Technological Progress in Treating Calcified Coronary Lesions JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-21 Michael P. Savage MD, David L. Fischman MD, Mamas A. Mamas MA DPhil BM BCh
-
Reply JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Chetan P. Huded, Suzanne V. Arnold, David J. Cohen, Adnan K. Chhatriwalla, John A. Spertus
-
Non–Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve Replacement JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Bashir Alaour, Enrico Ferrari, Dik Heg, David Tueller, Thomas Pilgrim, Olivier Muller, Stephane Noble, Raban Jeger, Oliver Reuthebuch, Stefan Toggweiler, Christian Templin, Peter Wenaweser, Fabian Nietlispach, Maurizio Taramasso, Christoph Huber, Marco Roffi, Stephan Windecker, Stefan Stortecky
-
Decoding Ticagrelor Dyspnea JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Alberto Giannoni, Claudio Passino, Francesco Gentile, Paolo Sciarrone, Michele Emdin
-
P2Y12 Inhibitors in Chronic Coronary Syndromes Undergoing Elective PCI JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 José Luis Ferreiro
-
Left Atrial Appendage Occlusion JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Apostolos Tzikas
-
National Variability in Pacemaker Implantation Rate Following TAVR JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Amit N. Vora, Hemal Gada, Pratik Manandhar, Andrezej Kosinski, Ajay Kirtane, Tamim Nazif, Michael Reardon, Susheel Kodali, David J. Cohen, Vinod Thourani, Matthew Sherwood, Howard Julien, Sreekanth Vemulapalli
-
Amulet Occluder Implantation in Patients With Failed Prior Left Atrial Appendage Occlusion JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Mohamad Alkhouli, Akash Makkar, James V. Freeman, Christopher R. Ellis, Atman P. Shah, Hemal Gada, Megan Coylewright, Monica Lo, Himanshu Agarwal, Dhanunjaya Lakkireddy
-
Pacemaker Implantation Rate Following TAVR JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 François Philippon
-
-
Reply JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Dominick J. Angiolillo, Davide Cao, Usman Baber, Roxana Mehran
-
Impact of Bleeding Risk and Inflammation on Cardiovascular Outcomes After Percutaneous Coronary Intervention JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Manish Vinayak, Davide Cao, Richard Tanner, Anoop N. Koshy, Serdar Farhan, Birgit Vogel, Samantha Sartori, Yihan Feng, Vishal Dhulipala, Ayush Arora, George D. Dangas, Annapoorna S. Kini, Samin K. Sharma, Roxana Mehran
-
3D-ICE–Guided Repair of a Persistent LVOT Pseudoaneurysm After Aortic Valve Replacement JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Abdullah Al-Abcha, Juan Crestanello, Mohamad Alkhouli
-
Inflammatory Potential and Risk Prediction After PCI in High Bleeding Risk Patients JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Usman Baber
-
Distal Radial Access Evolution JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Gregory A. Sgueglia
-
-
Transcatheter Aortic Valve Replacement in Asymptomatic Severe Aortic Stenosis JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Kyriakos Dimitriadis, Nikolaos Pyrpyris, Konstantina Aggeli, Konstantinos Tsioufis
-
Ticagrelor vs Clopidogrel for Complex Percutaneous Coronary Intervention in Chronic Coronary Syndrome JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Benoit Lattuca, Cedric Mazeau, Guillaume Cayla, Grégory Ducrocq, Paul Guedeney, Mikael Laredo, Raphaëlle Dumaine, Mohamad El Kasty, Petr Kala, Mohammed Nejjari, Ota Hlinomaz, Olivier Morel, Olivier Varenne, Florence Leclercq, Laurent Payot, Christian Spaulding, Farzin Beygui, Grégoire Rangé, Zuzana Motovska, Jean-Jacques Portal, Eric Vicaut, Jean-Philippe Collet, Gilles Montalescot, Johanne Silvain
-
Distal Radial Access for Coronary Procedures in a Large Prospective Multicenter Registry JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Jun-Won Lee, Yongcheol Kim, Bong-Ki Lee, Sang-Yong Yoo, Sang Yeub Lee, Chan Joon Kim, Han-Young Jin, Jin Sup Park, Jung Ho Heo, Do Hoi Kim, Jin Bae Lee, Dong-Kie Kim, Jun Ho Bae, Sung-Yun Lee, Seung-Hwan Lee
-
What Oral Anticoagulant Is Best After TAVR JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-12 Jurriën M. ten Berg, Daniël C. Overduin, Dirk-Jan van Ginkel
-
Should We Stent Vulnerable, But Asymptomatic, Lesions? JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-07 Nils P. Johnson MD MS, K. Lance Gould MD, Jagat Narula MD PhD
-
Presence and Relevance of Myocardial Bridge in LAD-PCI of CTO and Non-CTO Lesions JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-07 Kei Yamamoto MD, Yoichiro Sugizaki MD, Dimitri Karmpaliotis MD PhD, Takao Sato MD, Mitsuaki Matsumura BS, Shuro Narui MD, Myong Hwa Yamamoto MD, Khady N. Fall MD MPH, Elizabeth I. James BS, John B. Glinski BS, Maya L. Rabban BA, Megha Prasad MD MS, Vivian G. Ng MD, Sanjum S. Sethi MD, Tamim M. Nazif MD, Sahil A. Parikh MD, Torsten P. Vahl MD, Ziad A. Ali MD DPhil, LeRoy E. Rabbani MD, Michael B. Collins
Intravascular ultrasound (IVUS) studies show that one-quarter of left anterior descending (LAD) arteries have a myocardial bridge. An MB may be associated with stent failure when the stent extends into the MB. The aim of this study was to investigate: 1) the association between an MB and chronic total occlusion (CTO) in any LAD lesions; and 2) the association between an MB and subsequent clinical outcomes
-
In Memoriam: Professor Jean-Philippe Collet JACC Cardiovasc. Inte. (IF 11.3) Pub Date : 2024-02-07 Gilles Montalescot MD PhD